bmiMD Review (2026): $99 Semaglutide + 4-Point Lab Testing — Lowest-Priced Platform Tested

bmiMD's most distinctive structural feature in the 2026 U.S. telehealth GLP-1 weight-loss category is the lowest published semaglutide price we've identified across our 13-platform review set: $99/month for compounded semaglutide. That undercuts Oak's $133 (previously the floor in our review set) by $34/month, FeelGood's $149 by $50/month, SkinnyRx's $149.25 microdose by $50/month, and Ivy RX's $155 microdose by $56/month. The $139 tirzepatide is similarly category-leading, and $79 sermorelin for muscle growth or anti-aging is competitive with the rest of the men's-and-longevity-focused market. bmiMD's second most distinctive feature is its unusually detailed four-point lab testing disclosure: partner pharmacies perform third-party testing through FDA and DEA registered labs for potency, sterility, pH, and endotoxicity — more detailed pharmacy-quality transparency than most competitors in our review set provide. The notable caveats — and the main things keeping this rating at 4.3/5 rather than higher — are that bmiMD does not display LegitScript certification status on its landing page (we recommend verifying directly), and the platform doesn't name specific medical advisors or compounding pharmacy partners. The combination of $99 semaglutide + four-point lab testing is genuinely structurally distinctive — and worth weighing carefully against the missing trust-stack display.

What is bmiMD?

bmiMD (bmimd.com) is a U.S. telehealth platform offering prescription weight-loss medication, wellness products, and anti-aging treatments with the lowest published compounded GLP-1 pricing we've identified across our 13-platform 2026 review set. Compounded semaglutide is $99/month, compounded tirzepatide is $139/month, and sermorelin (oral or injection) is $79/month. Additional products include NAD+ injection and Lipo injection. Categories span Weight Loss, Mood+Energy, Strength+Cardio, Anti-Aging, and Everyday+.

Per bmiMD's own published positioning: "Transparent, upfront pricing — 100% online with support." The platform offers same-day online consultations with board-certified physicians, with medications shipped in 3-5 business days from U.S.-based licensed partner pharmacies. The pharmacy partners perform third-party testing through FDA and DEA registered labs across four quality measures — potency, sterility, pH, and endotoxicity — which bmiMD discloses directly on the platform.

The four-point lab testing — a structural transparency win

Most U.S. compounded GLP-1 platforms disclose that their partner pharmacies are state-licensed and FDA-registered. bmiMD goes a step further by disclosing the specific quality-control tests its partner pharmacies perform through FDA and DEA registered labs:

This level of pharmacy QC transparency is unusual in the U.S. compounded GLP-1 telehealth category. Most competitors mention "U.S. state-licensed pharmacies" without disclosing specific test types. bmiMD's four-point disclosure provides an objectively verifiable trust signal — patients can reference the specific tests when asking the partner pharmacy or comparing against industry compounding standards.

How bmiMD works (step-by-step)

bmiMD uses a streamlined three-step enrollment:

1. Answer health questions and complete your online visit. After placing your order, complete a quick medical questionnaire about your health and weight loss goals. Board-certified physicians offer same-day telehealth consults to evaluate your health data.
2. Receive medication. Once your prescription is approved, your medication and supplies are shipped directly to your door from a U.S.-based licensed partner pharmacy. Typical timeline: 3-5 business days.
3. Ongoing care and support. bmiMD members get instant access to chat with their board-certified physician or customer service team for medication management, refills, and program questions.

bmiMD pricing in 2026 — category-leading published rates

bmiMD publishes all of its core product pricing directly on the landing page — and the headline rates are the lowest we've identified across our 13-platform 2026 review set:

How bmiMD pricing compares to the rest of the category

bmiMD's $99 semaglutide is the new floor we've identified in our 13-platform 2026 review set. Direct comparisons (all rounded to nearest dollar):

• bmiMD $99 semaglutide — new lowest in our review set
• Oak $133 semaglutide — previous lowest, now $34/mo more than bmiMD
• FeelGood $149 semaglutide — $50/mo more than bmiMD
• SkinnyRx $149.25 microdose — $50/mo more (also includes overnight shipping)
• Ivy RX $155 microdose — $56/mo more
• Medvi $179-$299 semaglutide — $80-$200/mo more (LegitScript verified)
• TrimRx $179-$349 semaglutide — $80-$250/mo more (flat-rate guarantee)

If sticker price alone is your decision driver and you're comfortable verifying LegitScript status directly via LegitScript's merchant database (since bmiMD doesn't display the seal on its landing page), bmiMD's $99 headline is genuinely category-leading. Over a 12-month course at maintenance dose, the difference between $99/mo and competitors' $149-$179/mo is $600-$960 of patient out-of-pocket savings — a real number.

Medications bmiMD offers

bmiMD's medication menu spans five product categories — broader than typical GLP-1-only platforms:

• Compounded Tirzepatide Injection — $139/month — once-weekly dual GLP-1/GIP agonist. Same active ingredient as branded Zepbound and Mounjaro. Lowest published tirzepatide in our 2026 review set.
• Compounded Semaglutide Injection — $99/month — once-weekly GLP-1. Same active ingredient as branded Ozempic and Wegovy. Lowest published semaglutide in our review set.
• Sermorelin Injection — $79/month — growth hormone releasing peptide (GHRP) for muscle growth, anti-aging support, and better sleep. Competes with Fella Health's longevity stack.
• Oral Sermorelin — $79/month — oral tablet alternative to injection.
• NAD+ Injection — cellular energy and anti-aging support. Compare against Ivy RX's $199/mo NAD+ and Fella's $99/mo NAD+.
• Lipo Injection — fat-loss/weight support adjunct.

Are bmiMD medications compounded or FDA-approved?

bmiMD's medications are compounded, not FDA-approved as finished drug products. The platform prepares compounded semaglutide, tirzepatide, sermorelin, NAD+, and Lipo formulations through U.S. state-licensed compounding pharmacy partners under Section 503A of the FD&C Act. The same active pharmaceutical ingredients used in branded products are used in the compounded formulations, but the finished products are not individually FDA-reviewed for safety, efficacy, or quality.

What bmiMD does provide as a quality-control supplement is its four-point third-party lab testing (covered above): potency, sterility, pH, and endotoxicity tests through FDA and DEA registered labs. This doesn't substitute for FDA approval of the finished drug product, but it does provide independent verification of specific pharmacy quality measures that's more detailed than most competitors disclose.

The category-wide compounded caveat applies to every compounded GLP-1 provider, including Oak, TrimRx, Medvi, FeelGood, ReflexMD, SkinnyRx, Elevate Health, FuturHealth, Fella Health, and Ivy RX. For platforms offering FDA-approved branded options (Wegovy, Ozempic, Zepbound, Mounjaro) on the same platform, see Medvi, FeelGood, Elevate Health, or FuturHealth.

Side effects & safety

The GLP-1 side-effect profile is the same across all providers because the active ingredients are identical. Side effects to be aware of: nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and reduced appetite are common, particularly during early titration. For comprehensive management strategies, see our GLP-1 side effects guide.

GLP-1 medications carry a boxed warning for thyroid C-cell tumors based on animal studies (see the FDA prescribing information for semaglutide). Patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 syndrome should not use GLP-1 medications. Pregnancy is a contraindication. bmiMD's chat-with-physician option is useful for managing side-effect questions during titration.

Who bmiMD is best for

bmiMD is a strong fit if you:

• Want the absolute lowest published GLP-1 price we've identified in our 2026 review set ($99 semaglutide, $139 tirzepatide)
• Value the unusually detailed four-point lab testing disclosure (potency, sterility, pH, endotoxicity through FDA/DEA registered labs)
• Would benefit from sermorelin ($79/mo) for muscle growth, anti-aging, or sleep improvement on the same platform
• Want same-day physician consultation
• Are willing to verify LegitScript certification directly on LegitScript's merchant database rather than relying on a landing-page seal
• Want HSA/FSA acceptance
• Are comfortable with U.S. state-licensed partner pharmacy fulfillment without specific pharmacy names disclosed

bmiMD is not the best fit if you:

• Require visible LegitScript certification on the merchant's landing page — see Medvi, Fella, FuturHealth, or SkinnyRx
• Need FDA-approved branded options (Wegovy, Ozempic, Zepbound, Mounjaro) — see Medvi, FeelGood, or FuturHealth
• Want a money-back guarantee mechanism (see Fella's 5% threshold or FeelGood)
• Want a named medical advisory team (see Fella, FuturHealth, or MyStart)
• Need flat-rate pricing protection at higher doses (see TrimRx)
• Are pregnant, nursing, under 18, or have GLP-1 contraindications

Real-world bmiMD patient feedback

bmiMD claims "Thousands of Members, 1,000+ Reviews" on the landing page. Specific named member outcomes are showcased — Amber (lost 60 lbs), Barbara (lost 24 lbs), Renee (lost 48 lbs) — with verified-member-labeled testimonials across multiple product categories (Weight Loss, Mood+Energy, Strength+Cardio, Anti-Aging, Everyday+). The categorized testimonial approach is useful for buyers cross-shopping across product types beyond just GLP-1.

Aggregating publicly available patient sentiment, three themes emerge:

• Positive: The $99 semaglutide pricing generates consistently positive cost-related reviews. The four-point lab testing disclosure is cited as a quality reassurance. Same-day consultation speed is praised.
• Critical: Some buyers note that bmiMD does not display LegitScript certification on the landing page — a recurring concern in third-party reviews. Lack of named medical leadership is also flagged in some reviews.
• Transparency: Testimonials are labeled "bmiMD verified member," which is positive transparency (similar to Ivy RX's "Verified Customers"), though sample sizes and review platform methodology are not detailed.

bmiMD's $99 published semaglutide price is the new floor we've identified across our 13-platform 2026 review set. Combined with the four-point pharmacy lab testing disclosure, the pricing-to-quality ratio is genuinely category-leading — once you've verified LegitScript status directly.— Bartley Editorial Analysis

bmiMD vs alternatives

bmiMD wins clearly on published price floor and pharmacy lab testing transparency. Medvi wins on LegitScript visibility at a higher price. Oak was the previous price floor at $133. If you can verify LegitScript status directly via LegitScript's database and the four-point lab testing reassurance is meaningful to you, bmiMD's $99 is genuinely category-leading.

bmiMD pros and cons

bmiMD sign-up & ongoing-care checklists

bmiMD frequently asked questions

Honest verdict — should you choose bmiMD?

bmiMD earns its 4.3/5 editor's rating on the strength of two structural features that are genuinely category-leading in our 2026 U.S. telehealth GLP-1 review set. First, the $99 published semaglutide price is the new floor we've identified across our 13-platform review set — beating Oak's $133, FeelGood's $149, SkinnyRx's $149.25 microdose, and Ivy RX's $155 microdose by meaningful margins. Over a 12-month course at maintenance dose, the bmiMD-versus-competitors differential ranges from $408 to $960 in patient out-of-pocket savings. The $139 published tirzepatide is similarly the lowest we've identified. Second, the four-point third-party lab testing disclosure (potency, sterility, pH, endotoxicity through FDA and DEA registered labs) provides more detailed pharmacy quality-control transparency than most competitors in our review set offer — a real positive trust signal that helps offset the absence of a more visible third-party certification.

What pulls the rating down from a higher mark is the now-familiar pattern: bmiMD does not display LegitScript certification status on its landing page. Unlike Medvi, Fella, FuturHealth, and SkinnyRx — all of which prominently show the LegitScript seal (or in SkinnyRx's case, probationary status) — bmiMD does not. The absence isn't necessarily a red flag (the platform may hold LegitScript certification and simply not display the seal), but it does mean buyers should verify status directly on LegitScript's public merchant lookup database before signing up. Secondary issues: no named medical advisors, no specific compounding pharmacy partner names, no money-back guarantee mechanism, and member testimonial methodology not detailed.

The bottom line

If you value the lowest published GLP-1 price in our 2026 review set and want detailed pharmacy lab testing transparency, and you're willing to verify LegitScript certification status directly via LegitScript's merchant lookup database — bmiMD's $99 semaglutide is genuinely category-leading. If LegitScript visibility on the merchant's own site is non-negotiable, Medvi, Fella Health, or FuturHealth are stronger trust-stack choices at higher prices.

Published: June 3, 2026 · Last updated: June 3, 2026 · Pricing verified: June 2026 · Spot a factual issue? Tell our editors.